Towards eradication of hepatitis C virus from dialysis units

被引：17

作者：

Jadoul, Michel ^{[1
]}

Horsmans, Yves

机构：

[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, B-1200 Brussels, Belgium

来源：

LANCET | 2015年 / 386卷 / 10003期

关键词：

HEMODIALYSIS; EPIDEMIOLOGY; INFECTION;

D O I：

10.1016/S0140-6736(15)00381-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1514 / 1515

页数：2

共 12 条

[1]

Caro L, 2015, REV ANTIVIRAL THER I, V4

[2] Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients [J].

Fabrizi, F ;

Dulai, G ;

Dixit, V ;

Bunnapradist, S ;

Martin, P .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1071-1081

[3] Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS [J].

Fissell, Rachel B. ;

Karaboyas, Angelo ;

Bieber, Brian A. ;

Sen, Ananda ;

Li, Yun ;

Lopes, Antonio A. ;

Akiba, Takashi ;

Bommer, Juergen ;

Ethier, Jean ;

Jadoul, Michel ;

Pisoni, Ronald L. ;

Robinson, Bruce M. ;

Tentori, Francesca .

HEMODIALYSIS INTERNATIONAL, 2016, 20 (01) :38-49

[4] Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS [J].

Fissell, RB ;

Bragg-Gresham, JL ;

Woods, JD ;

Jadoul, M ;

Gillespie, B ;

Hedderwick, SA ;

Rayner, HC ;

Greenwood, RN ;

Akiba, T ;

Young, EW .

KIDNEY INTERNATIONAL, 2004, 65 (06) :2335-2342

[5] Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients [J].

Goodkin, David A. ;

Bieber, Brian ;

Gillespie, Brenda ;

Robinson, Bruce M. ;

Jadoul, Michel .

AMERICAN JOURNAL OF NEPHROLOGY, 2013, 38 (05) :405-412

[6] The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study [J].

Jadoul, M ;

Poignet, JL ;

Geddes, C ;

Locatelli, F ;

Medin, C ;

Krajewska, M ;

Barril, G ;

Scheuermann, E ;

Sonkodi, S ;

Goubau, P .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) :904-909

[7] Epidemiology and prevention of hepatitis C virus transmission in the hemodialysis setting [J].

Jadoul, Michel ;

Fabrizi, Fabrizio .

SEMINARS IN DIALYSIS, 2014, 27 (05) :449-+

[8] Impact of liver fibrosis staging in hepatitis C virus (HCV) patients with kidney failure [J].

Jadoul, Michel ;

Horsmans, Yves .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) :1108-1110

[9] New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease [J].

Kwo, Paul Y. ;

Badshah, Maaz B. .

CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (03) :235-241

[10]

Roth D, 2015, LANCET

← 1 2 →